Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


29.05.2017

2 Am J Pathol
1 BMC Cancer
2 Br J Dermatol
19 Cancer
8 Clin Exp Dermatol
12 Dermatol Online J
1 Int J Cancer
2 J Dermatol
4 J Invest Dermatol
1 Lancet
2 Lancet Oncol
7 N Engl J Med
1 Nat Rev Cancer
5 PLoS Genet
5 PLoS Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. MATSUSHITA T, Date M, Kano M, Mizumaki K, et al
    Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.
    Am J Pathol. 2017 Feb 8. pii: S0002-9440(17)30066.
    PubMed     Text format     Abstract available


  2. This Month in AJP.
    Am J Pathol. 2017;187:695.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. LI X, Li Z, Li X, Liu B, et al
    Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
    BMC Cancer. 2017;17:357.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. DOU J, Zhang L, Xie X, Ye L, et al
    Integrative analyses reveal biological pathways and key genes in psoriasis.
    Br J Dermatol. 2017 May 25. doi: 10.1111/bjd.15682.
    PubMed     Text format     Abstract available

  5. REICH K, Pinter A, Lacour JP, Ferrandiz C, et al
    Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a Phase 3 study.
    Br J Dermatol. 2017 May 19. doi: 10.1111/bjd.15666.
    PubMed     Text format     Abstract available


    Cancer

  6. DIELI-CONWRIGHT CM, Wong L, Waliany S, Bernstein L, et al
    An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy.
    Cancer. 2016 May 24. doi: 10.1002/cncr.30104.
    PubMed     Text format     Abstract available

  7. DROOGER JC, van Tinteren H, de Groot SM, Ten Tije AJ, et al
    A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
    Cancer. 2016 Jun 17. doi: 10.1002/cncr.30141.
    PubMed     Text format     Abstract available

  8. ROSS JS, Gay LM, Wang K, Ali SM, et al
    Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
    Cancer. 2016 Jun 10. doi: 10.1002/cncr.30102.
    PubMed     Text format     Abstract available

  9. LEREBOURS F, Rivera S, Mouret-Reynier MA, Alran S, et al
    Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French t
    Cancer. 2016 Jun 17. doi: 10.1002/cncr.30143.
    PubMed     Text format     Abstract available

  10. SZCZEPANIAK SLOANE RA, Gopalakrishnan V, Reddy SM, Zhang X, et al
    Interaction of molecular alterations with immune response in melanoma.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available

  11. BYRNE EH, Fisher DE
    Immune and molecular correlates in melanoma treated with immune checkpoint blockade.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available

  12. WESTPHAL D, Glitza Oliva IC, Niessner H
    Molecular insights into melanoma brain metastases.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available

  13. LIM SY, Menzies AM, Rizos H
    Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available

  14. PEREZ-GUIJARRO E, Day CP, Merlino G, Zaidi MR, et al
    Genetically engineered mouse models of melanoma.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available

  15. REDDY BY, Miller DM, Tsao H
    Somatic driver mutations in melanoma.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available

  16. EATON BR, Jiang R, Torres MA, Kahn ST, et al
    Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer.
    Cancer. 2016 Jun 21. doi: 10.1002/cncr.30142.
    PubMed     Text format     Abstract available

  17. GALIANO-CASTILLO N, Cantarero-Villanueva I, Fernandez-Lao C, Ariza-Garcia A, et al
    Telehealth system: A randomized controlled trial evaluating the impact of an internet-based exercise intervention on quality of life, pain, muscle strength, and fatigue in breast cancer survivors.
    Cancer. 2016 Jun 22. doi: 10.1002/cncr.30172.
    PubMed     Text format     Abstract available

  18. FRIESE CR, Li Y, Bondarenko I, Hofer TP, et al
    Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.
    Cancer. 2016 Oct 24. doi: 10.1002/cncr.30324.
    PubMed     Text format     Abstract available

  19. RAO R, Rivers A, Rahimi A, Wooldridge R, et al
    Genetic Ancestry using Mitochondrial DNA in patients with Triple-negative breast cancer (GAMiT study).
    Cancer. 2016 Sep 1. doi: 10.1002/cncr.30267.
    PubMed     Text format     Abstract available

  20. PATEL TA, Puppala M, Ogunti RO, Ensor JE, et al
    Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods.
    Cancer. 2017;123:114-121.
    PubMed     Text format     Abstract available

  21. BRIER MJ, Chambless DL, Gross R, Chen J, et al
    Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
    Cancer. 2016 Aug 29. doi: 10.1002/cncr.30318.
    PubMed     Text format     Abstract available

  22. WEN HY, Krystel-Whittemore M, Patil S, Pareja F, et al
    Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
    Cancer. 2017;123:131-137.
    PubMed     Text format     Abstract available

  23. FERRERO JM, Hardy-Bessard AC, Capitain O, Lortholary A, et al
    Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
    Cancer. 2016 Jul 14. doi: 10.1002/cncr.30170.
    PubMed     Text format     Abstract available

  24. DEGNIM AC, Dupont WD, Radisky DC, Vierkant RA, et al
    Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.
    Cancer. 2016 Jun 28. doi: 10.1002/cncr.30153.
    PubMed     Text format     Abstract available


    Clin Exp Dermatol

  25. HASEGAWA A, Shimomura Y, Kibune N, Koshio J, et al
    Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13128.
    PubMed     Text format    

  26. FALCONE D, Richters RJH, Uzunbajakava NE, van Erp PEJ, et al
    Risk factors associated with sensitive skin and potential role of lifestyle habits: a cross-sectional study.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13133.
    PubMed     Text format     Abstract available

  27. LUEANGARUN S, Subpayasarn U, Chakavittumrong P, Tempark T, et al
    Lupus panniculitis of the scalp presenting with linear alopecia along the lines of Blaschko.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13132.
    PubMed     Text format    

  28. IMAFUKU K, Hata H, Yanagi T, Kitamura S, et al
    Multiple skin cancers in patients with mycosis fungoides after long-term ultraviolet phototherapy.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13121.
    PubMed     Text format     Abstract available

  29. TOUS-ROMERO F, Prieto-Barrios M, Burillo-Martinez S, Santos Santamaria L, et al
    Oesophagitis dissecans superficialis in a patient with erosive oral lichen planus.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13130.
    PubMed     Text format    

  30. YANG PP, Peng J, Wu YY, Liu Z, et al
    Immunohistochemical evaluation of epidermal proliferation, differentiation and melanocytic density in symmetrical acrokeratoderma.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13118.
    PubMed     Text format     Abstract available

  31. CURTO-BARREDO L, Lopez-Aventin D, Gomez-Martin I, Pujol RM, et al
    Recurrent pruritic papules on the elbows as a localized form of polymorphous light eruption.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13131.
    PubMed     Text format    

  32. GARRITSEN FM, Kraag DE, de Graaf M
    Guttate psoriasis triggered by perianal streptococcal infection.
    Clin Exp Dermatol. 2017 May 22. doi: 10.1111/ced.13129.
    PubMed     Text format     Abstract available


    Dermatol Online J

  33. MATSUMOTO ME, Collins MK, Raptis A, Jedrych J, et al
    Multifocal primary cutaneous nodular amyloidosis.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  34. MOUNESSA JS, Box NF, Asdigian NL, Braunberger T, et al
    Portable equipment for taking dramatic sun-damage revealing photos at skin cancer prevention outreach events.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  35. BRAUNBERGER T, Mounessa J, Rudningen K, Dunnick CA, et al
    Global skin diseases on Instagram hashtags.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  36. FARAHNIK B, Beroukhim K, Nakamura M, Abrouk M, et al
    Use of an oral phosphodiesterase-4 inhibitor (apremilast) for the treatment of chronic, severe atopic dermatitis: a case report.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  37. WANG EA, Kao J, Cheng MY, Ma C, et al
    Severe pellagra masked by concurrent plaque psoriasis: a case report of a hidden diagnosis.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  38. LEVANDOSKI KA, Girardi NA, Loss MJ
    Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipient.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  39. VAUDREUIL AM, Stroud CM, Hsu S
    Psoriasis mimicking mycosis fungoides clinically.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  40. HENRIQUE DE S B XAVIER M, De Magalhaes E, Ferraz Oliveira G, Keltke Magalhaes M, et al
    A child with kwashiorkor misdiagnosed as atopic dermatitis.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  41. CLARK AK, Sarcon AK, Fung MAFA, Konia T, et al
    Malignancy-associated Sweet syndrome: acute febrile neutrophilic dermatosis associated with recurrence of metastatic cervical cancer.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  42. FLORES-TERRY MA, Zamberk Majlis P, Franco-Munoz M, Vera-Iglesias E, et al
    Dermatosis papular acantolitica de la vulva con buena respuesta a tacrolimus topico.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  43. HAWKINS SD, Barilla S, Feldman SR
    Web app based patient education in psoriasis - a randomized controlled trial.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available

  44. STRAZZULLA LC, Wu H, Heller M, Kim CC, et al
    An incomplete picture: challenges of partial biopsies in large diameter atypical melanocytic lesions.
    Dermatol Online J. 2017;23.
    PubMed     Text format     Abstract available


    Int J Cancer

  45. LI X, Liu H, Amos CI, Lee JE, et al
    A PGC1beta genetic variant associated with nevus count and melanoma mortality.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30802.
    PubMed     Text format    


    J Dermatol

  46. OHTSUKI M, Morita A, Igarashi A, Imafuku S, et al
    Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch.
    J Dermatol. 2017 May 23. doi: 10.1111/1346-8138.13911.
    PubMed     Text format     Abstract available

  47. HO PH, Tsai TF
    Development of bullous pemphigoid during secukinumab treatment for psoriasis.
    J Dermatol. 2017 May 23. doi: 10.1111/1346-8138.13909.
    PubMed     Text format    


    J Invest Dermatol

  48. PLASMEIJER EI, Nguyen TM, Olsen CM, Janda M, et al
    The natural history of common melanocytic naevi: a systematic review of longitudinal studies in the general population.
    J Invest Dermatol. 2017 May 18. pii: S0022-202X(17)31539.
    PubMed     Text format    

  49. KUNISADA M, Hosaka C, Takemori C, Nakano E, et al
    CXCL1 inhibition regulates UVB-induced skin inflammation and tumorigenesis in Xpa-deficient mice.
    J Invest Dermatol. 2017 May 17. pii: S0022-202X(17)31536.
    PubMed     Text format     Abstract available

  50. HAS C
    The "Kelch" Surprise: KLHL24, a New Player in the Pathogenesis of Skin Fragility.
    J Invest Dermatol. 2017;137:1211-1212.
    PubMed     Text format     Abstract available

  51. KONO M, Suga Y, Akashi T, Ito Y, et al
    A child with epidermolytic ichthyosis from a parent with epidermolytic nevus: risk evaluation of transmission from mosaic to germline.
    J Invest Dermatol. 2017 May 17. pii: S0022-202X(17)31542.
    PubMed     Text format    


    Lancet

  52. MAR VJ, Scolyer RA, Long GV
    Computer-assisted diagnosis for skin cancer: have we been outsmarted?
    Lancet. 2017;389:1962-1964.
    PubMed     Text format    


    Lancet Oncol

  53. JATOI I, Benson JR, Toi M
    De-escalation of axillary surgery in early breast cancer.
    Lancet Oncol. 2016;17:e430-e441.
    PubMed     Text format     Abstract available

  54. KAUFMAN HL, Russell J, Hamid O, Bhatia S, et al
    Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
    Lancet Oncol. 2016 Sep 1. pii: S1470-2045(16)30364.
    PubMed     Text format     Abstract available


    N Engl J Med

  55. MEHRTENS SH, Tharakaram S
    Extramammary Paget's Disease.
    N Engl J Med. 2017;376:e35.
    PubMed     Text format    


  56. Psoriatic Arthritis.
    N Engl J Med. 2017;376:2095-6.
    PubMed     Text format    

  57. ALI FR
    Psoriatic Arthritis.
    N Engl J Med. 2017;376:2095.
    PubMed     Text format    


  58. Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
    N Engl J Med. 2017;376:2092-2093.
    PubMed     Text format    

  59. RUZICKA T, Mihara R
    Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
    N Engl J Med. 2017;376:2093.
    PubMed     Text format    

  60. HAJDARBEGOVIC E, Balak DM
    Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
    N Engl J Med. 2017;376:2092.
    PubMed     Text format    

  61. CICCIA F, Triolo G, Rizzo A
    Psoriatic Arthritis.
    N Engl J Med. 2017;376:2094-5.
    PubMed     Text format    


    Nat Rev Cancer

  62. CARROLL JS, Hickey TE, Tarulli GA, Williams M, et al
    Deciphering the divergent roles of progestogens in breast cancer.
    Nat Rev Cancer. 2016 Nov 25. doi: 10.1038/nrc.2016.
    PubMed     Text format     Abstract available


    PLoS Genet

  63. RUMP A, Benet-Pages A, Schubert S, Kuhlmann JD, et al
    Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.
    PLoS Genet. 2016;12:e1006248.
    PubMed     Text format     Abstract available

  64. MAIR B, Konopka T, Kerzendorfer C, Sleiman K, et al
    Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity.
    PLoS Genet. 2016;12:e1006279.
    PubMed     Text format     Abstract available

  65. KASPAREK P, Ileninova Z, Zbodakova O, Kanchev I, et al
    KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype.
    PLoS Genet. 2017;13:e1006566.
    PubMed     Text format     Abstract available

  66. EVANS JM, Noorai RE, Tsai KL, Starr-Moss AN, et al
    Beyond the MHC: A canine model of dermatomyositis shows a complex pattern of genetic risk involving novel loci.
    PLoS Genet. 2017;13:e1006604.
    PubMed     Text format     Abstract available

  67. HAGENAARS SP, Hill WD, Harris SE, Ritchie SJ, et al
    Genetic prediction of male pattern baldness.
    PLoS Genet. 2017;13:e1006594.
    PubMed     Text format     Abstract available


    PLoS Med

  68. SAVAS P, Teo ZL, Lefevre C, Flensburg C, et al
    The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
    PLoS Med. 2016;13:e1002204.
    PubMed     Text format     Abstract available

  69. HOADLEY KA, Siegel MB, Kanchi KL, Miller CA, et al
    Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases.
    PLoS Med. 2016;13:e1002174.
    PubMed     Text format     Abstract available

  70. GOH G, Schmid R, Guiver K, Arpornwirat W, et al
    Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
    PLoS Med. 2016;13:e1002136.
    PubMed     Text format     Abstract available

  71. GUO Y, Warren Andersen S, Shu XO, Michailidou K, et al
    Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.
    PLoS Med. 2016;13:e1002105.
    PubMed     Text format     Abstract available

  72. LEUNG W, Kvizhinadze G, Nair N, Blakely T, et al
    Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis.
    PLoS Med. 2016;13:e1002067.
    PubMed     Text format     Abstract available


    PLoS One

  73. AHN SG, Lee JH, Lee HW, Jeon TJ, et al
    Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
    PLoS One. 2017;12:e0175048.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: